Open
Tax incentives for R&D in Canada
Canada
Pharmaceutical
Fund your projects in pharmaceuticals
Investments in R&D, testing, compliance, laboratory equipment, and commercialization can open the door to grants. helloDarwin helps identify the right programs for your industry.
What makes funding in pharmaceuticals complex
Pharmaceutical businesses often need to combine expenses, sector proof, intake dates, and economic objectives to secure the right funding.
Varied expenses
Equipment, technology, training, hiring, energy efficiency, or expansion can fall under different programs.
Sector-specific proof
Programs need to understand the context in pharmaceuticals, the budget, outcomes, and operational risks.
Timing requirements
Many programs require applications before the purchase, signature, or project start.
Grants in pharmaceuticals
Pharmaceutical businesses can access programs to modernize operations, develop markets, improve productivity, or reduce costs.
Open
Funding for feasibility studies and investment planning
Quebec, Canada
Closes on March 31, 2027
Up to 50,000 $
Open
Tax credit for investment and innovation in Quebec
Quebec, Canada
Accepted$500K-$1M
2025Manufacturing
Scientific Research and Experimental Development (SR&ED) - Tax Incentive Program
Advanced vehicle engineering and field testing
Accepted$50K-$100K
2025Manufacturing
Industrial Research Assistance Program (IRAP) — Financial Assistance
Digital transformation to improve efficiency
Accepted$50K-$100K
2025Manufacturing
Scientific Research and Experimental Development (SR&ED) - Tax Incentive Program
Digital modernization for traceability and automation
Accepted$50K-$100K
2024Professional, scientific and technical services
NovaScience Program — Support for the position of innovation and commercialization manager
Digital project to structure growth
Accepted$25K-$50K
2026Manufacturing
Scientific Research and Experimental Development (SR&ED) - Tax Incentive Program
Building-system R&D and thermal testing
Accepted$25K-$50K
2025Professional, scientific and technical services
Innovative Solutions Canada Program
Applied innovation project with commercial potential
Accepted$25K-$50K
2025Manufacturing
Scientific Research and Experimental Development (SR&ED) - Tax Incentive Program
Product engineering and performance testing
Accepted$25K-$50K
2024Professional, scientific and technical services
NovaScience Program — Support for employment in research and innovation
Digital project to structure growth
Accepted$10K-$25K
2026Canadian business
Scientific Research and Experimental Development (SR&ED) - Tax Incentive Program
Digital project to structure growth
Accepted$10K-$25K
2025Manufacturing
Mitacs — Accelerate Entrepreneur
Digital project to structure growth
Accepted$10K-$25K
2025Manufacturing
Mitacs Accelerate
Operational modernization with new tools
Our services
Precision expertise in high-impact funding vertical.
Grant Consulting
Strategic support to build your financing plan, prioritize opportunities, and manage your requests.
Grant Writing
Comprehensive support to prepare, draft, and file an accurate application with the help of our experts.
Platform
Self-service tools to discover grants, tax credits, and programs tailored to your projects.
Frequently asked questions
Need help deciding what applies to your business? Talk to an expert and get a clearer next step.
Which pharmaceutical projects can be reviewed for funding?
R&D, formulation, testing, validation, quality systems, automation, clinical or pre-commercial work, and technical documentation may open the door to grants, tax credits, or SR&ED support.
What documentation matters in pharmaceutical files?
Funders and tax-credit reviewers often need technical plans, testing records, expense tracking, regulatory context, timelines, and evidence that the work goes beyond routine operations.
How does helloDarwin help choose the right funding path?
We separate grant, tax-credit, and SR&ED opportunities, then help match each part of the project to the right program, claim period, documentation standard, and submission timeline.